LETTER
A Synthetic Route To Macrocyclic cis-3-Phenylproline Derivatives
191
(8) Abbreviation used are the follows: PyBROP, bromotripyrro-
linophosphonium hexafluorophosphate; DIEA, diisopropyl-
ethylamine; PyCl/I, N-methyl-2-chloropyridinium iodide
(Mukaiyama reagent); HOBt, 1-hydroxybenzotriazole; EDCI,
1-(3-dimethylaminopropyl)-3-ethylcarbodiimine hydrochlo-
ride.
(9) Sakaitani, M., Ohfune, Y., J. Org. Chem., 1990, 55, 870.
(10) a) The spacer compound 15a (white solid, mp 255°C, Rf 0.64
nButanol/H2O/AcOH 4/1/1) was synthesised by the condensa-
tion of (4-aminobutyl)carbamic acid 1,1-dimethylethyl ester
(Muller, D.; Zeltser, I.; Bitan, G.; Gilon C. J. Org. Chem.,
1997, 62, 411) with (R)-2-bromo-3-phenylpropionic acid
(Fournie-Zaluski, M-C.; Coulaud, A.; Bouboutou, R.; Chail-
let, P.; Devin, J.; Walsman, G.; Costentin, J.; Roques, B. P. J.
Med. Chem., 1985, 28, 1158) in 48% yield (CH2Cl2, rt., 4
days).
References and Notes
(1) For an excellent review, see : Fairlie, E. J.; Abbenante, G.;
March, D. Curr. Med. Chem., 1995, 2, 654 and references ci-
ted therein.
(2) Previous works in this field, see : Damour, D.; Barreau, M.;
Blanchard, J-C.; Burgevin, M-C.; Doble, A.; Herman, F.;
Pantel, G.; James-Surcouf, E.; Vuilhorgne, M.; Mignani, S.,
Poitou, L., Le Merrer, Y., Depezay, J-C. Bioorg. Med. Chem.
Lett., 1996, 6, 1667; Damour, D.; Barreau, M.; Blanchard, J-
C.; Burgevin, M-C.; Doble, A.; Labaudinière R ; Pantel, G.;
Mignani, S., Chem.Lett., 1998, 943. Damour, D.; Barreau, M.;
Blanchard, J-C.; Burgevin, M-C.; Doble, A.; Pantel, G.;
Labaudinière, R.; Mignani, S. Bioorg. Med. Chem., submitted
for publication .
(3) Hirschmann, R.; Nicolaou, K. C.; Pietranico, S.; Leahy, E. M.;
Salvino, J.; Arison, B.; Cichy, M. A.; Spoors, P. G.; Shake-
speare, W. C.; Sprengeler, P. A.; Hamley, P.; Smith, A. B.;
Reisine, T.; Raynor, K.; Maechler, L.; Donaldson, C.; Vale,
W.; Freidinger, R. M.; Cascieri, M. R.; Strader, C.D. J. Am.
Chem. Soc., 1993, 115, 12550; Papageorgiou, C.; Haltiner, R.;
Bruns C.; Petcher, T. Bioorg. Med. Chem. Lett., 1992, 2, 135;
Papageorgiou, C.; Borer, X. Bioorg. Med. Chem. Lett., 1996,
6, 267; Goodman, M.; Zhang, J. Chemtracts-Organic Chemi-
stry, 1997, 10, 629 and references cited therein.
(4) Molecular dynamics simulations and other computational pro-
cedures were performed with the Discover and Insight II pak-
kage ( MSI, 10065 Barnes Canyon Rd, San Diego, CA 92121,
USA) and in-house tools.
(5) All new compounds synthesised herein gave satisfactory ana-
lytical and spectroscopic data (1H-NMR , IR , MS , Elemental
Analyses); see footnote (14) as an example for 2b.
(6) a) The macrocyclisation of 18a affording 19a is given hereaf-
ter as representative experimental procedure using PyCl/I as
coupling reagent. To a stirred solution of 18a (21 g, 2.3
mmol), DMAP (2.6 g, 21.3 mmol), and CH2Cl2 (300 ml) was
added in small portions PyCl/I (0.8 g, 3.1 mmol) and the resul-
ting mixture stirred for 1h at room temperature and then reflu-
xed for 3h under nitrogen atmosphere. After completion
(monitored by TLC), the reaction mixture was allowed to cool
to room temperature and diluted with water (150 ml). The or-
ganic phase was dried with MgSO4, filtered and evaporated.
The resulting crude compound was purified by flash chroma-
tography on silica gel (eluant: CH2Cl2/MeOH mixture 95/5 to
give 0.57 g of 19a (37 %) as a white solid.
b) The spacer compound 15b (yellow solid, mp 202°C, Rf 0.66
CH2Cl2/MeOH 95/5) was prepared by condensation of (3-
aminobenzyl)-carbamic acid tert-butyl ester (Bock, M. G.; Di-
pardo, R. M.; Evans, B. E.; Rittle, K. E.; Whitter, W. L.;
Garsky, V. M.; Gilbert, K. F.; Leighton, J. L.; Carson, K. L.;
Mellin, E. C.; Veber, D. F.; Chang, R. S. L.; Lotti, V. J.; Freed-
man, S. B.; Smith, A. J.; Patel, S.; Anderson, P. S.; Freidinger,
R. M. J. Med. Chem., 1993, 36, 4276) with 3-phenyl-2-trifluo-
romethanesulfonyloxypropionic acid methyl ester (Effenber-
ger, F.; Burkard, U.; Willfahrt, J. Liebigs Ann. Chem, 1986,
314) followed by hydrolysis (1N NaOH, THF, rt, 12 h) in 78%
overall yield.
c) The spacer compound 15c (cream solid, mp 135°C, Rf 0.13
CH2Cl2/MeOH 90/10) was prepared by the condensation of
2(2-Boc-amino-ethyl)naphth-7-yl-3-propionic acid (Sarabu,
R., Lovey, K., Madison, V. S., Fry, D. C., Greeley, D. N.,
Cook, C. M., Olson, G. L., Tetrahedron, 1993, 49, 3629) with
L-phenyl alanine methyl ester (BOP, THF, DIEA, MeCN, rt.,
12 h) followed by action of 1N NaOH (EtOH, 40°C, 2 h) in
89% overall yield.
(11) The spacer 15d (cream solid, mp 130°C, Rf 0.40 nButanol/
H2O/AcOH 4/1/1) was prepared by action of (S)-2-(hydroxy-
butylamino)-3-phenylpropionic acid with acetyl chloride/
conc.HCl in THF (rt., 12h) in 49% overall yield. The (S)-2-
(hydroxybutylamino)-3-phenylpropionic acid was prepared
by the condensation of (R)-2-bromo-3-phenylpropionic acid
(see ref. 9a) with 4-hydroxy-butylamine (CH2Cl2, 48h, rt.) in
48% overall yield.
(12) For representative examples of macrocyclisation using PyCl/I
(Mukaiyama reagent), see: Mukaiyama, T, Angew. Chem. Int.
Ed. Engl., 1979, 18, 707; Hamada, T., Zenkoh, T., Sato, H.,
Yonemitsu, O, Tetrahedron Lett., 1991, 32, 1649; Rico, I.,
Halvorsen, K., Dubrule, C., Lattes, A., J. Org. Chem., 1994,
59, 415 and references cited therein.
(13) For representative examples of macrocyclisation using BOP,
see: Hale, K. J., Cai, J., Williams, G., Synlett, 1998, 2, 149;
Shin, C-G., Okumura, K., Shigekuni, M., Nakamura, Y.,
Chem. Lett., 1998, 2, 139; Dudash, J., Jiang, J., Scott, C. M.,
Joullié, M. M., Syn. Comm., 1993, 23, 349 and references ci-
ted therein.
b) The macrocyclisation of 18b affording 19b is given here-
after as representative experimental procedure using BOP as
coupling reagent. To solution of 18b (5.1g, 5.5 mmol) and
MeCN (1l) was added in small portion BOP (2.4g, 5.5 mmol)
at 0°C under nitrogen atmosphere. Then, a solution of TEA
(2.4 g, 3.2 ml, 23.2 mmol) in MeCN (100 ml) was added drop-
wise at the same temperature. The reaction mixture was allo-
wed to stir for a further 1 h at 0°C, and then was stirred at room
temperature for 3 h. After completion (monitored by TLC),
the solvent was evaporated to dryness under reduced pressure
and the residue washed with water (200 ml). Then, TEA was
added until basic pH and the solution was extracted with
EtOAc (2 x 100 ml). The combined organic phase was con-
centrated in vacuo, and the resulting yellow oil purified by
flash chromatography on silica gel (eluant: EtOAc/MeOH
mixture 99/1) to give 1.9g of crude 19b which was purified by
preparative HPLC (Porasil /Waters) eluting with: CH2Cl2/
MeOH mixture 98/2 to afford pure 19b (1.15g, 30%) as a whi-
te solid.
(14) 2a: cream solid, mp 242°C, aD20 = +6 (MeOH, C = 0.5); 2b:
white solid, mp 109°C, aD20 = +6.2 (MeOH, C = 0.5);
2b(2HCl.H2O): white solid mp 15°C; 2c: cream solid, mp
148°C, aD20 = +66 (MeOH, C = 0.5); 2d: grey solid, mp 112°C
(hygroscopic).
(15) The NMR, IR and MS data and elemental analyses of 2b are
given hereafter as representative data: NMR (DMSO,
500MHz , 343 K) : 8.3 (1H) d , J=7 , H2 ; 8 (2H) bs , terminal
NH2 ; 7.2 to 7.4 (12H) complex m , phenyls , H5 and H8 ; 7.1
(1H) t , J=8, H2’’; 6.95 (1H) bd , J=8 , H3’’; 6.7 (1H) bd, J=8
, H1’’; 6.5 (1H) bs ,H7; 5 (1H) d , J=8 , H15; 4.45 (1H) dd ,
(7) Chung, J. Y. L., Wasicak, J. T., Arnold, W. A. , May, C. S.,
Nadzan, A. M., Holladay, M. W. J. Org. Chem., 1990, 55, 270
and references cited therein.
Synlett 1999, No. 2, 189–192 ISSN 0936-5214 © Thieme Stuttgart · New York